Scalper1 News
Top-rated medical stocks Regeneron Pharmaceuticals (REGN) and Abiomed (ABMD) both hit new highs on the stock market early Tuesday after both companies beat quarterly earnings estimates and raised guidance. Regeneron reported Q2 earnings of $2.89 a share excluding one-time items, up 17% from the year-earlier quarter and 12 cents above analysts’ consensus, according to Thomson Reuters. Revenue jumped 50% to $999 million, $11 million above consensus. Scalper1 News
Scalper1 News